EUVIMEDEUVIMED entdecken
Crossref

Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?

Dieter Haffner, Maren Leifheit-Nestler

Kidney International · 2025

DOI: 10.1016/j.kint.2025.02.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2025. Verfasst von Dieter Haffner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany. Electronic address: haffner.d…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Renal Insufficiency, Chronic, Mitochondria, Heart, Receptor, Fibroblast Growth Factor, Type 4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: Chiesi Farmaceutici, Kyowa Kirin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease is associated with excessive cardiovascular mortality, which is promoted by the phosphaturic hormone fibroblast growth factor 23 (FGF23). Increased FGF23 levels result in left ventricular hypertrophy via activation of the FGF receptor 4 activation. Fuchs et al. now demonstrate, using bioengineered cardiobundles, neonatal rat ventricular myocytes, and mice with chronic kidney disease, that FGF23-FGF receptor 4 activation is a potential mechanism of cardiac mitochondrial dysfunction and metabolic remodeling as early complications of chronic kidney disease, preceding structural cardiac changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth FactorsRenal Insufficiency, ChronicMitochondria, HeartReceptor, Fibroblast Growth Factor, Type 4AnimalsFibroblast Growth Factor-23RatsMiceHumansMyocytes, CardiacHypertrophy, Left Ventricular

Substanzen

Fibroblast Growth FactorsFibroblast Growth Factor-23Fgf23 protein, mouseReceptor, Fibroblast Growth Factor, Type 4Fgf23 protein, ratFGF23 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany. Electronic address: haffner.dieter@mh-hannover.de.
  • Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany.

Förderung

  • Chiesi Farmaceutici
  • Kyowa Kirin

Zitieren

APA

Haffner, D., & Leifheit-Nestler, M. (2025). Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?. Kidney International. https://doi.org/10.1016/j.kint.2025.02.017

Vancouver

Haffner D, Leifheit-Nestler M. Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?. Kidney International. 2025. doi:10.1016/j.kint.2025.02.017

BibTeX
@article{Haffner2025,
  author = {Haffner, Dieter and Leifheit-Nestler, Maren},
  title = {Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?},
  journal = {Kidney International},
  year = {2025},
  doi = {10.1016/j.kint.2025.02.017}
}
Kostenlos starten →